Pretreatment with lipopolysaccharide modulates innate immunity in corneal fibroblasts challenged with Aspergillus fumigatus.
Xiaoyan Zhang
Department of Ophthalmology, Qilu Hospital of Shandong University, Wenhua Xi Road 107, Jinan, Shandong, P.R. China.
Xinyi Wu
Li Gao
D001228:Aspergillosis / Q000276:immunology* / Q000503:physiopathology; D001232:Aspergillus fumigatus / Q000276:immunology* / Q000472:pathogenicity; D002460:Cell Line; D002465:Cell Movement / Q000187:drug effects; D003315:Cornea / Q000473:pathology; D016207:Cytokines / Q000276:immunology / Q000378:metabolism; D005347:Fibroblasts / Q000187:drug effects / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D007108:Immune Tolerance; D007113:Immunity, Innate / Q000187:drug effects; D007634:Keratitis; D007963:Leukocytes, Mononuclear / Q000378:metabolism* / Q000473:pathology; D008070:Lipopolysaccharides / Q000494:pharmacology; D051197:Toll-Like Receptor 4 / Q000276:immunology / Q000378:metabolism*
D016207:Cytokines; D008070:Lipopolysaccharides; C495345:TLR4 protein, human; D051197:Toll-Like Receptor 4